SEC Form 4 · accession 0000899243-18-020780
OMEROS CORP · OMER
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marcia S. Kelbon
Officer — VP Patent and General Counsel
Period of report
Jul 26, 2018
Accepted (ET)
Jul 30, 2018 · 7:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001285819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 26, 2018 | M | 35,000 | $4.10 | A | 219,645 | D | |
| Common StockF2 | Jul 26, 2018 | S | 35,000 | $21.5339 | D | 184,645 | D | |
| Common Stock | Jul 26, 2018 | M | 8,000 | $6.05 | A | 192,645 | D | |
| Common Stock | Jul 27, 2018 | M | 5,723 | $4.10 | A | 198,368 | D | |
| Common StockF3 | Jul 27, 2018 | S | 5,723 | $21.7293 | D | 192,645 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4 | $4.10 | Jul 26, 2018 | M | 35,000 | D | — | Jan 7, 2022 | Common Stock | 35,000 | 48,252 | D |
| Stock Option (Right to Buy)F5 | $6.05 | Jul 26, 2018 | M | 8,000 | D | — | Mar 28, 2020 | Common Stock | 8,000 | 61,996 | D |
| Stock Option (Right to Buy)F4 | $4.10 | Jul 27, 2018 | M | 5,723 | D | — | Jan 7, 2022 | Common Stock | 35,000 | 42,529 | D |
Explanation of responses
- F1Open market sale pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. The trading schedule, including sale periods, price and the number of shares to be sold, was established in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The sale was planned in advance for purposes including funding ongoing home construction and the exercise and holding of certain Omeros options.
- F2This transaction was executed in multiple trades at prices ranging from $21.45 to $21.63; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
- F3This transaction was executed in multiple trades at prices ranging from $21.48 to $21.90; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
- F4The option vested and became exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2011.
- F5On July 26, 2018, the reporting person paid the exercise price and exercised options to purchase 8,000 shares of the company's common stock. The shares have not been sold and are held for the account of the reporting person. The options previously vested and became exercisable in 48 equal monthly installments, with a vesting commencement date of April 1, 2010.